Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Sleep Initiation and Maintenance Disorders 8Anxiety Disorders 6Neoplasms 5Fatigue 4Lymphoma 3Depression 3Breast Neoplasms 3Prostatic Neoplasms 2Nervous System Diseases 2Lymphoma, Follicular 2Glioma 2Weight Loss 1Weight Gain 1Uterine Cervical Neoplasms 1Tobacco Use Disorder 1Substance-Related Disorders 1Sleep Wake Disorders 1Sedentary Behavior 1Ovarian Neoplasms 1Oligodendroglioma 1Neoplasm Metastasis 1Myasthenia Gravis 1Multiple Myeloma 1Mental Disorders 1Meningioma 1Melanoma 1Medication Adherence 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Hepatitis B 1

Interventions

pembrolizumab 137Nivolumab 116Ipilimumab 68Cyclophosphamide 33Specimen Handling 31Magnetic Resonance Spectroscopy 28trametinib 23binimetinib 22fludarabine 21Interleukin-2 20dabrafenib 19relatlimab 17encorafenib 17Biopsy 17CTLA-4 Antigen 16cemiplimab 15atezolizumab 15aldesleukin 15Radiosurgery 15fludarabine phosphate 14Opdualag 14Radiotherapy 11lenvatinib 10Blood Specimen Collection 10lifileucel 9Paclitaxel 8Cisplatin 8Bevacizumab 8spartalizumab 7cobimetinib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Melanoma × Cognitive Behavioral Therapy × 1 year × Clear all
NCT07379138 2026-01-30

Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients

Mayo Clinic

Phase NA Recruiting
350 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡